153 related articles for article (PubMed ID: 3783208)
21. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
22. [Interstitial brachytherapy for malignant gliomas using the Brown-Roberts-Wells (BRW) stereotactic system].
Matsumoto K; Tomita S; Sakurai M; Maeshiro T; Matsuhisa T; Tsuno K; Kunishio K; Mishima N; Furuta T; Nishimoto A
No Shinkei Geka; 1990 Sep; 18(9):829-36. PubMed ID: 2172851
[TBL] [Abstract][Full Text] [Related]
23. 125I interstitial brachytherapy for primary malignant brain tumors: technical aspects of treatment planning and implantation methods.
Findlay PA; Wright DC; Rosenow U; Harrington FS; Miller RW
Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):2021-6. PubMed ID: 4055458
[TBL] [Abstract][Full Text] [Related]
24. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
[TBL] [Abstract][Full Text] [Related]
25. Computer applications to radioactive-seed: brain-tumor implants.
Meli JA; Dicker CS; Schulz RJ
Comput Med Imaging Graph; 1989; 13(3):269-74. PubMed ID: 2541891
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
[TBL] [Abstract][Full Text] [Related]
27. [Current status and future perspectives of interstitial 125I seed implantation treatment for malignant tumors].
Cao XF; Lü J
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):81-3. PubMed ID: 22780922
[No Abstract] [Full Text] [Related]
28. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas.
Loeffler JS; Alexander E; Hochberg FH; Wen PY; Morris JH; Schoene WC; Siddon RL; Morse RH; Black PM
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1455-62. PubMed ID: 2262370
[TBL] [Abstract][Full Text] [Related]
29. A new technique of brachytherapy for malignant gliomas with caesium-137: a new method utilizing a remote afterloading system.
Ashpole RD; Snyman H; Bullimore JA; Appleby HJ; Cummins BH; Coakham HB
Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):333-7. PubMed ID: 2278891
[TBL] [Abstract][Full Text] [Related]
30. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
[TBL] [Abstract][Full Text] [Related]
31. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
32. [Extension of polynomial analysis of interstitial I-125 brachytherapy for 48 months].
Kolumbán Z; Major T; Julow J
Ideggyogy Sz; 2011 Jul; 64(7-8):235-8. PubMed ID: 21863690
[TBL] [Abstract][Full Text] [Related]
33. [125-I brachytherapy of pineal parenchymal tumours in two patients and review of the literature].
Julow J; Viola A; Major T; Valálik I; Sági S; Mangel L; Kovács RB; Hável J; Kiss T
Ideggyogy Sz; 2005 Jul; 58(7-8):254-62. PubMed ID: 16175667
[TBL] [Abstract][Full Text] [Related]
34. Malignant glioma: patterns of failure following individually tailored limited volume irradiation.
Hess CF; Schaaf JC; Kortmann RD; Schabet M; Bamberg M
Radiother Oncol; 1994 Feb; 30(2):146-9. PubMed ID: 8184112
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
36. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
37. Image fusion guided brachytherapy of brain tumors.
Julow J
Ideggyogy Sz; 2010 May; 63(5-6):164-9. PubMed ID: 20648780
[TBL] [Abstract][Full Text] [Related]
38. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
39. Normal brain irradiation during stereotactic brain implants using radioactive iodine-125.
Jani SK; Hitchon PW; VanGilder JC; Wen BC
Appl Neurophysiol; 1987; 50(1-6):310-3. PubMed ID: 3329869
[TBL] [Abstract][Full Text] [Related]
40. A CT-based computerized treatment planning system for I-125 stereotactic brain implants.
Weaver K; Smith V; Lewis JD; Lulu B; Barnett CM; Leibel SA; Gutin P; Larson D; Phillips T
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):445-54. PubMed ID: 2406230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
